<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>High intraglomerular pressure is associated with renal hyperfiltration, leading to the initiation and progression of <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> in experimental models of <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (DM) </plain></SENT>
<SENT sid="1" pm="."><plain>In humans, hyperfiltration is observed in patients with type 1 and type 2 DM, and is also seen in patients with <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> conditions, such as the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>From a mechanistic perspective, both vascular and tubular factors likely contribute to the pathogenesis of hyperfiltration </plain></SENT>
<SENT sid="3" pm="."><plain>Until now, human studies have primarily focused on the use of medications that inhibit the renin angiotensin system to reduce efferent vasoconstriction and thereby improve hyperfiltration </plain></SENT>
<SENT sid="4" pm="."><plain>More recent advances in the development of investigational <z:chebi fb="3" ids="16335">adenosine</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi> and inhibitors of <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="105" ids="17234">glucose</z:chebi> co-transport may help to elucidate tubular factors that contribute to afferent vasodilatation </plain></SENT>
<SENT sid="5" pm="."><plain>In this review, we summarize available data from experimental and human studies of type 1 and type 2 DM and <z:hpo ids='HP_0001513'>obesity</z:hpo> to provide an overview of factors that contribute to the hyperfiltration state </plain></SENT>
<SENT sid="6" pm="."><plain>We have focused on the renin angiotensin system, cyclooxygenase-2 system, nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi>, protein kinase C and endothelin as vascular determinants of hyperfiltration </plain></SENT>
<SENT sid="7" pm="."><plain>We also discuss relevant tubular factors, since experimental models have suggested that inhibition of <z:chebi fb="199" ids="26708">sodium</z:chebi>-<z:chebi fb="105" ids="17234">glucose</z:chebi> cotransport may be renoprotective </plain></SENT>
</text></document>